Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
127.7 USD | +0.13% | -1.96% | +17.02% |
02/05 | Merck: encouraging results in gastric cancer | CF |
01/05 | Merck Says Keytruda Meets Primary Endpoint in Late-Stage Gastric Cancer Trial | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.02% | 323B | |
+31.52% | 690B | |
+25.31% | 546B | |
-5.21% | 358B | |
+5.01% | 287B | |
+14.49% | 235B | |
+5.24% | 199B | |
-9.94% | 195B | |
+3.98% | 161B | |
-2.19% | 159B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Merck Posts Higher Q1 Adjusted Earnings, Sales; Raises Full-Year 2022 Outlook